Immunosuppressive agents for treating IgA nephropathy
IgA nephropathy is a kidney condition, leading to kidney failure for many of those who are affected. About 10-20% of patients require dialysis or a kidney transplant within 10 years, and 30-40% within 20 years, from their disease onset. This long time between diagnosis and kidney failure makes it difficult to establish the most effective and safest treatment. In August 2015, Marinella Ruospo and her colleagues from Bari, Italy updated their Cochrane Review of immunosuppressive therapies and she tells us what they have found in this podcast. (Source: Podcasts from The Cochrane Library)
Source: Podcasts from The Cochrane Library - February 2, 2017 Category: General Medicine Authors: Cochrane Source Type: podcasts
" Spin Off " -- The Discovery Files
Cotton candy machines have inspired a new way to build capillary structures necessary to make full-scale artificial livers, kidneys, bones and other essential organs. While some may call the approach a little crazy, engineers have shown the machines make possible a simple technique to make microfluidic networks that mimic the three-dimensional capillary system in the human body in a cell-friendly fashion. (Source: The Discovery Files)
Source: The Discovery Files - March 8, 2016 Category: Science Authors: National Science Foundation Source Type: podcasts
How Does Dialysis Care Differ for Minority Patients?
A large study found that patients from racial minority groups were less likely to receive certain types of dialysis or to receive kidney transplants. (Source: Medscape Nephrology Podcast)
Source: Medscape Nephrology Podcast - February 2, 2016 Category: Urology & Nephrology Authors: Medscape Source Type: podcasts
@OncEd Presents Dr. Philip Halloran - Identifying T Cell-Mediated Inflammation in Tissue by Molecular Phenotyping: Lessons from Kidney Transplantation - Canadian Melanoma Conference 2015
Author: oncologyeducation
Added: 12/02/2015 (Source: Oncology Tube)
Source: Oncology Tube - December 2, 2015 Category: Cancer & Oncology Source Type: podcasts
Donald E. Hricik, MD - Considering Comorbidities and Adherence in the Long-Term Management of Kidney Transplant Recipients: Optimizing Immunosuppressive Therapy in the Context of Current Evidence
Considering Comorbidities and Adherence in the Long-Term Management of Kidney Transplant Recipients: Optimizing Immunosuppressive Therapy in the Context of Current Evidence (Source: PeerView Press CME/CE International Audio Podcast - Internal Medicine)
Source: PeerView Press CME/CE International Audio Podcast - Internal Medicine - October 2, 2015 Category: Internal Medicine Authors: PVI, PeerView Institute for Medical Education Tags: Science, Medicine Source Type: podcasts
Referrals From Dialysis Facilities for Kidney Transplantation
Interview with Rachel E. Patzer, PhD, MPH, author of Variation in Dialysis Facility Referral for Kidney Transplantation Among Patients With End-Stage Renal Disease in Georgia. This population epidemiology study uses United States Renal Data System data to characterize dialysis facility–level referral for kidney transplant evaluation in Georgia, the US state with the lowest transplantation rates, and patient and facility factors associated with referral and waitlisting. (Source: JAMA Author Interviews)
Source: JAMA Author Interviews - August 11, 2015 Category: Journals (General) Authors: The JAMA Network Source Type: podcasts
Stanley C. Jordan, MD, FASN - To Minimize or Not To Minimize: Examining the Impact of Reduced Immunosuppression After Kidney Transplantation
To Minimize or Not To Minimize: Examining the Impact of Reduced Immunosuppression After Kidney Transplantation (Source: PeerView Press CME/CE International Audio Podcast - Internal Medicine)
Source: PeerView Press CME/CE International Audio Podcast - Internal Medicine - June 19, 2015 Category: Internal Medicine Authors: PVI, PeerView Institute for Medical Education Tags: Science, Medicine Source Type: podcasts
Robert S. Gaston, MD - Immunosuppression for Kidney Transplant Recipients: How to Maximize Outcomes and Minimize Graft Failure
Immunosuppression for Kidney Transplant Recipients: How to Maximize Outcomes and Minimize Graft Failure (Source: PeerView CME/CE Audio Podcast - Pathology)
Source: PeerView CME/CE Audio Podcast - Pathology - September 11, 2014 Category: Pathology Authors: PVI, PeerView Institute for Medical Education Tags: Science, Medicine Source Type: podcasts
Kidney Transplant Medications: Using ramipril to control protein in urine
Don Holzheimer received a kidney transplant from his brother. Afterwards, he volunteered to participate in a clinical trial extending the use of a medication (ramipril) that has been used to control blood pressure to also control levels of protein in urine. This clinical trial also replaces calcineurin inhibitors (cyclosporine or Prograf) with sirolimus (Rapamune) to balance the effect of immunosuppressant medications. He has responded well to the medication and his doctor will be prescribing the use of this experimental mediation to continue. He reviews the experience of participating and the benefits of participating i...
Source: MUSC Organ Transplantation Surgery Podcast - April 5, 2014 Category: Transplant Surgery Authors: Medical Univeristy of South Carolina Source Type: podcasts
Transplant: Superior Services at MUSC
Dr. Kenneth Chavin, a specialist in transplant surgery, comments on a recent honor of MUSC’s transplant services, which was named the number one liver transplant program in the country by the University Health Consortium. He notes specific initiatives and strategies employed by the transplant team at MUSC to achieve their high level of success. Dr. Chavin emphasizes the importance of the multidisciplinary approach and notes that MUSC has the shortest wait time in the country for both liver and kidney transplants. (Source: MUSC Organ Transplantation Surgery Podcast)
Source: MUSC Organ Transplantation Surgery Podcast - April 5, 2014 Category: Transplant Surgery Authors: Medical Univeristy of South Carolina Source Type: podcasts
Transplant: Kidney Transplant
Head of the Division of Transplant Surgery at MUSC, Dr. Prabhakar Baliga, discusses causes for a patient requiring a kidney transplant. He also talks about kidney dialysis, pointing to the advantage of transplant for both quality of life and longevity. Dr. Baliga explains the growing success rate of kidney transplants from live donors, including unrelated donors. (Source: MUSC Organ Transplantation Surgery Podcast)
Source: MUSC Organ Transplantation Surgery Podcast - April 5, 2014 Category: Transplant Surgery Authors: Medical Univeristy of South Carolina Source Type: podcasts
Donating a Kidney
Mary Hart, an administrative specialist at the MUSC Children’s Hospital, discusses her personal experience of donating a kidney. She describes her reasons for deciding to volunteer for the procedure, what the recovery experience was like, and how this has affected her life since that time. (Source: MUSC Organ Transplantation Surgery Podcast)
Source: MUSC Organ Transplantation Surgery Podcast - April 5, 2014 Category: Transplant Surgery Authors: Medical Univeristy of South Carolina Source Type: podcasts
Kidney Transplant: The Advantages of Living Donor Kidney Transplant
Dr. Prabakhar Baliga, director of the division of transplant surgery at MUSC, discusses the significant advantages of obtaining a donor kidney from a living person. He explains how significant advances in anti-rejection medications have made this procedure much more feasible between two non-genetically related individuals. (Source: MUSC Organ Transplantation Surgery Podcast)
Source: MUSC Organ Transplantation Surgery Podcast - April 5, 2014 Category: Transplant Surgery Authors: Medical Univeristy of South Carolina Source Type: podcasts
